Mycophenolic Acid Delayed-Release Tablets USP 360 mg

Name: Mycophenolic Acid Delayed-Release Tablets USP 360 mg
Brand: ANAVRIN LIFE SCIENCES
Price: 265 INR
Availability: InStock

Price 265 INR/ Strip

Get a Price/Quote

MOQ : 10 Packs

Mycophenolic Acid Delayed-Release Tablets USP 360 mg Specification

Pacakaging (Quantity Per Box)
10 x 1 x 10 Tablet

Origin of Medicine
India

Drug Type
General Medicines

Physical Form
Tablets

Dosage
360 mg

Dosage Guidelines
As per suggestion

Suitable For
Suitable For All

Storage Instructions
Dry place

Mycophenolic Acid Delayed-Release Tablets USP 360 mg Trade Information

Minimum Order Quantity
10 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Mycophenolic Acid Delayed-Release Tablets USP 360 mg

Experience the latest in immunosuppressive therapy with Mycophenolic Acid Delayed-Release Tablets USP 360 mg. These exquisite tablets are designed for reduced gastrointestinal side effects, reserving their majestic efficacy for patients undergoing organ transplantation. Manufactured and exported by a leading supplier from India, this splendid formulation delivers a consistent 360 mg dosage with every tablet. The medicine comes securely packed-10 blisters of 10 tablets each-ensuring prolonged stability when stored in a dry place. Consult your physician for dosage guidelines. Suitable for all as directed, upholding high standards of safety and quality.

Exquisite Features and Splendid Uses

Mycophenolic Acid Delayed-Release Tablets USP 360 mg feature a moisture-resistant coating for extended potency. Suitable for use in hospitals, clinics, and specialty care centers, these tablets offer majestic control in preventing organ rejection. They are well-suited for diverse patient profiles, with dosage flexibility as per medical guidance. Their delayed-release mechanism ensures optimal absorption and therapeutic benefit while reducing side effects, making them a vital component in modern immunosuppressive regimens.

Packaging, Supply, and Shipment Details

Each box contains 10 strips of 10 tablets, meticulously packaged for maximum stability during shipment and storage. The robust packaging guarantees product integrity from manufacturer to end-user. With a reliable supply ability, prompt shipment is ensured to both domestic and international clients. Sample policy may be available on request, reflecting the supplier's commitment to customer satisfaction and seamless global logistics. Secure packaging and steady supply underline the exporter's focus on quality and service.

FAQ's of Mycophenolic Acid Delayed-Release Tablets USP 360 mg:

Q: How should Mycophenolic Acid Delayed-Release Tablets USP 360 mg be stored?

A: These tablets should be kept in a dry place, away from direct sunlight and moisture, to maintain their effectiveness and prolong shelf life.

Q: What is the recommended usage of Mycophenolic Acid Delayed-Release Tablets?

A: Dosage should follow your healthcare provider's suggestion. The tablets are generally suitable for all prescribed patients, particularly those needing immunosuppressive therapy after organ transplantation.

Q: When is Mycophenolic Acid Delayed-Release typically administered?

A: This medication is commonly given as part of a post-transplant regimen to help prevent organ rejection, with timing and dosage determined by a physician.

Q: Where can Mycophenolic Acid Delayed-Release Tablets USP 360 mg be used?

A: They are intended for use in medical settings such as hospitals, clinics, and specialized care centers under professional supervision.

Q: What is the supply process and packaging format for these tablets?

A: The product is supplied in boxes containing 10 strips of 10 tablets each. Packaging is designed for secure, moisture-resistant shipment to both domestic and international locations.

Q: What are the main benefits of the delayed-release formulation?

A: The delayed-release design reduces gastrointestinal side effects while ensuring optimal absorption and efficacy, contributing to improved patient tolerance and outcomes.

Tell us about your requirement